Growing community of inventors

London, United Kingdom

Rakesh Parmar

Average Co-Inventor Count = 9.47

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Rakesh ParmarJeffrey McKenna (2 patents)Rakesh ParmarPaul Wright (2 patents)Rakesh ParmarMahbub Ahmed (2 patents)Rakesh ParmarJoseph McKenna (2 patents)Rakesh ParmarAlexander Ashall-Kelly (2 patents)Rakesh ParmarLouisa Gueritz (2 patents)Rakesh ParmarSimon Mutton (2 patents)Rakesh ParmarGraham Charles Bloomfield (1 patent)Rakesh ParmarJon Shepherd (1 patent)Rakesh ParmarJon Sheperd (1 patent)Rakesh ParmarJeffrey Mckenna (0 patent)Rakesh ParmarJoseph Mckenna (0 patent)Rakesh ParmarRakesh Parmar (2 patents)Jeffrey McKennaJeffrey McKenna (13 patents)Paul WrightPaul Wright (8 patents)Mahbub AhmedMahbub Ahmed (7 patents)Joseph McKennaJoseph McKenna (5 patents)Alexander Ashall-KellyAlexander Ashall-Kelly (2 patents)Louisa GueritzLouisa Gueritz (2 patents)Simon MuttonSimon Mutton (2 patents)Graham Charles BloomfieldGraham Charles Bloomfield (12 patents)Jon ShepherdJon Shepherd (1 patent)Jon SheperdJon Sheperd (1 patent)Jeffrey MckennaJeffrey Mckenna (0 patent)Joseph MckennaJoseph Mckenna (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (2 from 3,923 patents)


2 patents:

1. 9359381 - Tricyclic compounds for inhibiting the CFTR channel

2. 9303035 - Substituted pyrazino[1',2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…